Dennis Choi, MD | PhD


Dr. Dennis Choi is Professor of Neurology at Stony Brook University, having previously worked as Director of the Brain Science Institute at the Korea Institute of Science and Technology, Executive Vice President at the Simons Foundation, Vice President for Academic Health Affairs at Emory University, Executive Vice President for Neuroscience at Merck Research Labs, and Head of Neurology at Washington University.

Dr. Choi received his M.D. from the Harvard-MIT Health Sciences and Technology Program, as well as a Ph.D. in pharmacology and neurology residency training at Harvard. A fellow of the American Association for the Advancement of Science and a member of the National Academy of Medicine, he has served as President of the Society for Neuroscience, Vice-President of the American Neurological Association, and chairman of the U.S./Canada Regional Committee of the International Brain Research Organization.

He has been a member of the Board on Life Sciences of the National Academy of Sciences; the Nervous System Drugs Advisory Committee to the U.S. Food & Drug Administration; and Councils for the National Institute of Neurological Disorders and Stroke, the National Institute on Aging, the Winter Conference for Brain Research, the International Society for Cerebral Blood Flow and Metabolism, and the Neurotrauma Society; as well as the advisory boards of multiple non-profit disease foundations and companies.

He has been a pioneer in developing the field of neuroprotection: identifying mechanisms responsible for nervous system injury in disease states, especially ischemia and trauma, and developing therapeutic countermeasures.


Amprion has some important news we need to share with you!

To improve patient access to the SYNTap® biomarker test (CSF), Amprion is reducing the self-pay price for tests with service dates on or after July 1, 2023.

Old self-pay price: $1500.00. New self-pay price: $995.00

Effective July 1, 2023, there is a New ABN (Advanced Beneficiary Notification) form for use when ordering the SYNTap® biomarker test (CSF) for patients on Medicare. Order Process

CPT/PLA – The SYNTap® test has been issued a dedicated PLA code to be used when billing: 0393U
We have applied to be a medicare provider and will soon be able to courtesy bill Medicare for your patients.